World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
122
Citations
65007
World Ranking
311
National Ranking
197

Medicine

D-Index
122
Citations
65228
World Ranking
3433
National Ranking
1891

Michael P. Busch publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael P. Busch sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 855 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael P. Busch D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael P. Busch sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 122 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael P. Busch is affiliated with the University of California, San Francisco in the United States. Their research primarily falls within the field of Medicine, with a focused contribution to Infectious Diseases, Epidemiology, Hematology, Public Health, Environmental and Occupational Health, and Virology.

The scientist's recent published papers illustrate an emphasis on SARS-CoV-2 and COVID-19 research, contributing to the understanding of the virus's spread, seroprevalence, and immune response through analyses of clinical and epidemiological data. Notable papers include:

  • "Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence" (2021) published in The Lancet
  • "Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic" (2021) published in Science
  • "Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021" (2021) published in JAMA
  • "Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray" (2021) published in Nature Communications
  • "Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance" (2020) published in Nature Microbiology

Frequent co-authors in their publications include Mars Stone, Eduard Grebe, Clara Di Germanio, Brian Custer, and Graham Simmons. This network of collaboration suggests a sustained research partnership within their areas of study.

The scientist's work is often published in venues specializing in transfusion medicine, infectious diseases, and clinical research. Predominant publication venues consist of:

  • Transfusion
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Vox Sanguinis
  • Clinical Infectious Diseases

Their main research topics cover several key areas related to viral diseases and public health, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • Blood donation and transfusion practices
  • Mosquito-borne diseases and control

Best Publications

  • Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

    David L. Thomas;Chloe L Thio;Maureen P. Martin;Ying Qi

  • The Risk of Transfusion-Transmitted Viral Infections

    George B. Schreiber;Michael P. Busch;Steven H. Kleinman;James J. Korelitz

  • Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

    Brandon F. Keele;Elena E. Giorgi;Elena E. Giorgi;Jesus F. Salazar-Gonzalez;Julie M. Decker

  • Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

    Eberhard W Fiebig;David J Wright;Bhupat D Rawal;Patricia E Garrett

  • Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero

    Jeff E. Mold;Jakob Michaëlsson;Trevor D. Burt;Marcus O. Muench

  • New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes

    Robert S. Janssen;Glen A. Satten;Susan L. Stramer;Bhupat D. Rawal

  • THE SEROEPIDEMIOLOGY OF HUMAN HERPESVIRUS 8 (KAPOSI’S SARCOMA-ASSOCIATED HERPESVIRUS): DISTRIBUTION OF INFECTION IN KS RISK GROUPS AND EVIDENCE FOR SEXUAL TRANSMISSION

    Dean H. Kedes;Eva Operskalski;Michael Busch;Robert Kohn

  • Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.

    Ester C Sabino;Lewis F Buss;Maria P S Carvalho;Carlos A Prete

  • Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

    Susan L. Stramer;Simone A. Glynn;Steven H. Kleinman;D. Michael Strong

  • Time trends in primary HIV-1 drug resistance among recently infected persons.

    Robert M. Grant;Frederick M. Hecht;Maria Warmerdam;Lea Liu

  • A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.

    Michael P. Busch;Simone A. Glynn;Susan L. Stramer;D. Michael Strong

  • Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.

    Lewis F Buss;Carlos A Prete;Claudia M M Abrahim;Alfredo Mendrone

  • Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma.

    M Schwab;J Ellison;M Busch;W Rosenau

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases

    Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano

  • Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

    M.P. Busch;L.L.L. Lee;G.A. Satten;D.R. Henrard

  • Current and Emerging Infectious Risks of Blood Transfusions

    Michael P. Busch;Steven H. Kleinman;George J. Nemo

  • Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

    Frederick M. Hecht;Michael P. Busch;Bhupat Rawal;Marcy Webb

  • The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy

    Darrell J. Triulzi;Steven Kleinman;Ram M. Kakaiya;Michael. P. Busch

  • Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks

    Judith A. Hahn;Kimberly Page-Shafer;Paula J. Lum;Philippe Bourgois

  • Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996.

    Simone A. Glynn;Steven H. Kleinman;George B Schreiber;Michael P. Busch

Frequent Co-Authors

Tzong-Hae Lee
Tzong-Hae Lee Blood Systems Research Institute
Steven Kleinman
Steven Kleinman University of British Columbia
Philip J. Norris
Philip J. Norris University of California, San Francisco
Edward L. Murphy
Edward L. Murphy University of California, San Francisco
Sheila M. Keating
Sheila M. Keating University of California, San Francisco
Ester C. Sabino
Ester C. Sabino Universidade de São Paulo
Susan L. Stramer
Susan L. Stramer American Red Cross
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Eric Delwart
Eric Delwart University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related online degrees like psychiatric mental health nurse practitioner programs offer promising options. Many students seek the best online pmhnp programs that not only provide quality education but also strong clinical placement rates, essential for hands-on experience.

Affordability is another crucial factor when choosing a program. Numerous students benefit from exploring affordable pmhnp programs that balance cost with comprehensive training, ensuring accessibility without compromising quality.

Career advancement is a key consideration, and understanding the salary landscape helps set realistic goals. The highest paid dnp specialties often correlate with additional certifications and specializations, encouraging continuous professional development.

Shifting specialties is also a common pathway. For example, those currently certified as family nurse practitioners can explore an acute care certification for fnp to expand their practice scope in acute care settings, opening new career opportunities.

Best Scientists Citing Michael P. Busch

Trending Scientists

Recently Published Articles